LGND (Ligand Pharmaceuticals Incorporated) operates in the Health technology sector. It's currently trading at $319.43. Our composite momentum score rates it 65/110 based on price +3.1% (1d), rvol 1.7x — elevated volume, rsi 75.5 — overbought, roc9 +11.5% — sharp acceleration, macd 9.11 — strong bullish crossover, and analyst: strong buy. Up 21.4% across 3 tracked price points, from Jul 7, 2026 to Jul 8, 2026.